In the last trading session, 1.12 million shares of the uniQure N.V (NASDAQ:QURE) were traded, and its beta was 0.09. Most recently the company’s share price was $15.50, and it changed around $0.34 or 2.24% from the last close, which brings the market valuation of the company to $848.60M. QURE currently trades at a discount to its 52-week high of $19.18, offering almost -23.74% off that amount. The share price’s 52-week low was $3.73, which indicates that the current value has risen by an impressive 75.94% since then.
uniQure N.V stock received a consensus recommendation rating of Buy, based on a mean score of 1.29. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 2 recommended QURE as a Hold, whereas 9 deemed it a Buy, and 0 rated it as Underweight.
uniQure N.V (NASDAQ:QURE) trade information
Instantly QURE has showed a green trend with a performance of 2.24% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 16.00 on recent trading dayincreased the stock’s daily price by 3.12%. The company’s shares are currently down -12.23% year-to-date, but still up 5.37% over the last five days. On the other hand, uniQure N.V (NASDAQ:QURE) is 9.31% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $27, which translates to bulls needing to increase their stock price by 42.59% from its current value. Analyst projections state that QURE is forecast to be at a low of $24 and a high of $30.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -9.66%. uniQure N.V earnings are expected to increase by 29.11% in 2025, but the outlook is positive 37.73% per year for the next five years.
QURE Dividends
uniQure N.V’s next quarterly earnings report is expected to be released in June.
NANTAHALA CAPITAL MANAGEMENT, LLC, with 5.4511% or 2.65 million shares worth $11.87 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
SPDR SERIES TRUST-SPDR(R) S&P(R) Biotech ETF and abrdn Healthcare Investors were the top two Mutual Funds as of Apr 30, 2025 . The former held 987.12 shares worth $15.3 million, making up 1.80% of all outstanding shares. On the other hand, abrdn Healthcare Investors held roughly 812.69 shares worth around $12.6 million, which represents about 1.48% of the total shares outstanding.
